APPROVED THROUGH
8/85 SUJECT TO THE CONDITIONS ESTABLISHED IN THE 8/29/84 LETTER
FROM JAMES B. MACRAE JR. TO ROBERT SERMIER.
Inventory as of this Action
Requested
Previously Approved
08/31/1985
08/31/1985
80
0
0
1,840
0
0
0
0
0
THESE GUIDELINES HAVE BEEN ESTABLISHED
TO PROVIDE SPONSORS WITH DETAILED INSTRUCTIONS ON SEEKING FDA
RECOMMENDATIONS ON ORPHAN DRUG PROTOCOLS AND/OR FDA DESIGNATIONS OF
AN ORPHAN DRUG.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.